Author:
Zhang Hui,Ding Lan,Zou Yi,Hu Shui-Qing,Huang Hai-Guo,Kong Wei-Bao,Zhang Ji
Funder
National Natural Science Foundation of China
Northwest Normal University
Publisher
Springer Science and Business Media LLC
Subject
Physical and Theoretical Chemistry,Computer Science Applications,Drug Discovery
Reference36 articles.
1. Björnsson E (2006) Drug-induced liver injury: Hy’s rule revisited. Clin Pharmacol Ther 79(521–528):1
2. Fung M, Thornton A, Mybeck K, Hsiao-Hui W, Hornbuckle K, Muniz E (2001) Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets 1960 to 1999. Drug Inf J 35:293–317
3. Chen MJ, Vijay V, Shi Q, Liu ZC, Fang H, Tong WD (2011) FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today 16:696–703
4. Oda S, Matsuo K, Nakajima A, Yokoi T (2016) A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury. Toxicol Lett 241:60–70
5. Food and Drug Administration (2009) Guidance for industry drug-induced liver injury: premarketing clinical evaluation. Food and Drug Administration, Silver Spring, MD, pp 38035–38036
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献